PlayAGS - AGS Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PlayAGS in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AGS shares.
View AGS analyst ratings or view top-rated stocks.

4 equities research analysts have issued 1-year price targets for PlayAGS's stock. Their AGS share price forecasts range from $9.00 to $14.00. On average, they anticipate the company's stock price to reach $11.50 in the next year. This suggests a possible upside of 108.7% from the stock's current price.
View analysts price targets for AGS or view top-rated stocks among Wall Street analysts.

PlayAGS's stock was trading at $6.79 at the beginning of 2022. Since then, AGS stock has decreased by 18.9% and is now trading at $5.51.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our AGS earnings forecast.

PlayAGS Inc (NYSE:AGS) released its quarterly earnings data on Monday, August, 8th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.07. The business earned $76.58 million during the quarter, compared to analyst estimates of $74.35 million. PlayAGS had a negative trailing twelve-month return on equity of 33.94% and a negative net margin of 7.66%.

138 employees have rated PlayAGS Chief Executive Officer David Lopez on Glassdoor.com. David Lopez has an approval rating of 95% among the company's employees. This puts David Lopez in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 81.0% of employees surveyed would recommend working at PlayAGS to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other PlayAGS investors own include Sorrento Therapeutics (SRNE), Energy Transfer (ET), Wells Fargo & Company (WFC), Catalyst Pharmaceuticals (CPRX), Earthstone Energy (ESTE), Allena Pharmaceuticals (ALNA), Helix Energy Solutions Group (HLX), ConocoPhillips (COP), Gulfport Energy (GPOR) and ImmunoGen (IMGN).

(AGS) raised $175 million in an initial public offering (IPO) on Friday, January 26th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Credit Suisse, Deutsche Bank Securities, Jefferies, Macquarie Capital, BofA Merrill Lynch, Citigroup, Nomura, Stifel and SunTrust Robinson Humphrey served as the underwriters for the IPO and Roth Capital Partners, Union Gaming, The Williams Capital Group and Apollo Global Securities were co-managers.

PlayAGS trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGS."

PlayAGS's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Goldman Sachs Group Inc. (9.25%), Renaissance Technologies LLC (3.64%), Deutsche Bank AG (2.75%), Emerald Mutual Fund Advisers Trust (2.22%), Millennium Management LLC (0.84%) and Emerald Advisers LLC (0.58%).
View institutional ownership trends.

Shares of AGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGS stock can currently be purchased for approximately $5.51.

PlayAGS (NYSE:AGS) has a market capitalization of $204.81 million and generates $259.70 million in revenue each year. The company earns $-22,570,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

PlayAGS's mailing address is 5475 S. DECATUR BLVD. SUITE #100, LAS VEGAS NV, 89118. The official website for the company is www.playags.com. The company can be reached via phone at 702-722-6700 or via email at jboguslawski@playags.com.